StockData
AEON Biopharma, Inc. logo

AEON Biopharma, Inc. (AEON) stock

AEONNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.11−0.03 (-19.40%)

Close on Nov 17, 2026Market cap $5.66MP/E –Yield –

AEON Biopharma enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

AEON Biopharma's enterprise value was $1.08M on Nov 11, 2026, against $3.94M a year earlier. Over the last 4 years it ranged from -$4.38M to $1.45B, with a median of $8.17M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.08M-84.3%
2025Dec 31, 2025$6.88M-67.0%
2024Dec 31, 2024$20.84M-91.7%
2023Dec 29, 2023$251.35M–

More AEON Biopharma figures

See a number that looks wrong?